I agree that this site is using cookies. You can find further informations here.
X
Fiveash, A.
568  results:
Search for persons X
?
1

Correction: "Commissioning and clinical evaluation of the I..:

Covington, Elizabeth L. ; Stanley, Dennis N. ; Sullivan, Rodney J....
Journal of Applied Clinical Medical Physics.  25 (2024)  8 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
2

Comparison of Biofilm Growth and Quorum Sensing Molecules i..:

Sanchez, Asley ; Alimiran, Fnu ; Gandhi, Kushal...
Microbiology Research.  15 (2024)  3 - p. 1486-1493 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Clinical trials of R-(-)-gossypol (AT-101) in newly diagnos..:

Fiveash, John B. ; Ye, Xiaobu ; Peerboom, David M....
PLOS ONE.  19 (2024)  1 - p. e0291128 , 2024
Link: https://doi.org/10.1371/..
 
?
4

Teaching Fifth-Grade Students With Specific Learning Disabi..:

Riccomini, Paul J. ; Hughes, Elizabeth E. ; Deshpande, Divya...
Learning Disability Quarterly.  47 (2024)  2 - p. 124-136 , 2024
Link: https://doi.org/10.1177/..
 
?
5

Overall survival for arm I and arm II separately (NABTT 060..:

John B. Fiveash ; Xiaobu Ye ; David M. Peerboom...
doi:10.1371/journal.pone.0291128.g005.  , 2024
Link: https://doi.org/10.1371/..
 
?
6

TREND checklist:

John B. Fiveash ; Xiaobu Ye ; David M. Peerboom...
doi:10.1371/journal.pone.0291128.s002.  , 2024
Link: https://doi.org/10.1371/..
 
?
7

Patient characteristics—NABTT 0602 (Newly diagnosed gliobla..:

John B. Fiveash ; Xiaobu Ye ; David M. Peerboom...
doi:10.1371/journal.pone.0291128.t001.  , 2024
Link: https://doi.org/10.1371/..
 
?
8

Grade 3 or higher toxicity combined arms I and II (NABTT 06..:

John B. Fiveash ; Xiaobu Ye ; David M. Peerboom...
doi:10.1371/journal.pone.0291128.t003.  , 2024
Link: https://doi.org/10.1371/..
 
?
9

AT-101 single agent objective response in patient with recu..:

John B. Fiveash ; Xiaobu Ye ; David M. Peerboom...
doi:10.1371/journal.pone.0291128.g006.  , 2024
Link: https://doi.org/10.1371/..
 
?
10

Overall survival for arm I and arm II separately (NABTT 060..:

John B. Fiveash ; Xiaobu Ye ; David M. Peerboom...
doi:10.1371/journal.pone.0291128.g005.  , 2024
Link: https://doi.org/10.1371/..
 
?
11

CONSORT diagram for NABTT 0602 and NABTT 0702:

John B. Fiveash ; Xiaobu Ye ; David M. Peerboom...
doi:10.1371/journal.pone.0291128.g003.  , 2024
Link: https://doi.org/10.1371/..
 
?
12

Clinical research protocol:

John B. Fiveash ; Xiaobu Ye ; David M. Peerboom...
doi:10.1371/journal.pone.0291128.s001.  , 2024
Link: https://doi.org/10.1371/..
 
?
13

Patient characteristics—NABTT 0702 (Recurrent patients):

John B. Fiveash ; Xiaobu Ye ; David M. Peerboom...
doi:10.1371/journal.pone.0291128.t002.  , 2024
Link: https://doi.org/10.1371/..
 
?
14

Grade 3 or 4 toxicity events with possibly, probably, or de..:

John B. Fiveash ; Xiaobu Ye ; David M. Peerboom...
doi:10.1371/journal.pone.0291128.t004.  , 2024
Link: https://doi.org/10.1371/..
 
?
15

TREND checklist:

John B. Fiveash ; Xiaobu Ye ; David M. Peerboom...
doi:10.1371/journal.pone.0291128.s002.  , 2024
Link: https://doi.org/10.1371/..
 
1-15